Advanced Search

Home Health & Hospice Week

Industry News:

Alzheimer's Patients May Have New Hope

Published on Wed Sep 09, 2009

Telltale proteins may single out which patients will get full-blown disease. A combination of proteins in the cerebrospinal fluid could help single out which patients with dementia will go on to develop full-blown Alzheimer's disease. The results of a major international study conducted by a research team at the University of Gothenburg, Sweden, confirmed early studies that hinted at this link, according to a recent press release. While there is currently no medication that can change the course of Alzheimer's, it's likely that medicines under development will have the biggest impact if they are used early on, said Dr. Niklas Mattsson of the Institute of Neuroscience and Physiology at the University of Gothenburg's Sahlgrenska Academy. Changes in the brain are reflected in the cerebrospinal fluid (CSF) in the form of biomarkers, researchers found. Previous smaller studies have shown that finding the proteins beta-amyloid, tau, and phosphorylated tau in the CSF [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Home Health & Hospice Week

View All